| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 44 | 2023 | 550 | 4.530 |
Why?
|
| Hyaluronic Acid | 23 | 2023 | 102 | 3.890 |
Why?
|
| Proteoglycans | 42 | 2020 | 345 | 3.060 |
Why?
|
| Aggrecans | 27 | 2023 | 157 | 2.780 |
Why?
|
| ADAM Proteins | 13 | 2015 | 66 | 2.290 |
Why?
|
| Extracellular Matrix Proteins | 27 | 2023 | 131 | 2.180 |
Why?
|
| Osteoarthritis | 16 | 2015 | 384 | 1.980 |
Why?
|
| Chondroitin Sulfates | 23 | 2018 | 30 | 1.960 |
Why?
|
| Animals | 82 | 2022 | 4723 | 1.800 |
Why?
|
| Glycosaminoglycans | 23 | 2023 | 53 | 1.590 |
Why?
|
| Fibroblasts | 4 | 2020 | 93 | 1.340 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 287 | 1.310 |
Why?
|
| Hyaluronan Receptors | 6 | 2012 | 33 | 1.270 |
Why?
|
| Osteoarthritis, Knee | 5 | 2019 | 400 | 1.210 |
Why?
|
| Transforming Growth Factor beta1 | 7 | 2019 | 32 | 1.150 |
Why?
|
| Wound Healing | 7 | 2020 | 174 | 1.020 |
Why?
|
| Versicans | 5 | 2020 | 17 | 1.020 |
Why?
|
| Horse Diseases | 2 | 2016 | 4 | 0.940 |
Why?
|
| Ligaments | 2 | 2016 | 15 | 0.930 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 466 | 0.930 |
Why?
|
| Mice | 20 | 2022 | 1683 | 0.880 |
Why?
|
| Achilles Tendon | 5 | 2019 | 19 | 0.860 |
Why?
|
| Endopeptidases | 6 | 2011 | 30 | 0.840 |
Why?
|
| Chondrocytes | 10 | 2015 | 208 | 0.830 |
Why?
|
| Keratan Sulfate | 9 | 2008 | 27 | 0.800 |
Why?
|
| Viscosupplements | 2 | 2012 | 11 | 0.780 |
Why?
|
| Cartilage | 13 | 2022 | 159 | 0.760 |
Why?
|
| Proteolysis | 2 | 2020 | 13 | 0.750 |
Why?
|
| Stromal Cells | 3 | 2020 | 37 | 0.750 |
Why?
|
| Glucosamine | 4 | 2009 | 9 | 0.740 |
Why?
|
| Cattle | 29 | 2019 | 219 | 0.730 |
Why?
|
| Knee Injuries | 3 | 2017 | 238 | 0.730 |
Why?
|
| Transforming Growth Factor beta | 6 | 2016 | 124 | 0.720 |
Why?
|
| Dermatan Sulfate | 8 | 2018 | 8 | 0.660 |
Why?
|
| Fibrosis | 6 | 2017 | 39 | 0.660 |
Why?
|
| Bone and Bones | 3 | 2017 | 126 | 0.650 |
Why?
|
| Synovial Fluid | 7 | 2011 | 127 | 0.640 |
Why?
|
| Lectins, C-Type | 15 | 2023 | 111 | 0.600 |
Why?
|
| Glucuronosyltransferase | 2 | 2015 | 6 | 0.590 |
Why?
|
| Pyridones | 1 | 2017 | 13 | 0.590 |
Why?
|
| ADAMTS5 Protein | 8 | 2018 | 30 | 0.580 |
Why?
|
| Signal Transduction | 5 | 2018 | 498 | 0.580 |
Why?
|
| Gene Expression | 5 | 2016 | 239 | 0.580 |
Why?
|
| Carrier Proteins | 8 | 2016 | 103 | 0.550 |
Why?
|
| Adipose Tissue | 1 | 2016 | 78 | 0.530 |
Why?
|
| Male | 28 | 2022 | 16445 | 0.520 |
Why?
|
| RNA | 1 | 2015 | 38 | 0.520 |
Why?
|
| Horses | 7 | 2016 | 19 | 0.510 |
Why?
|
| Genome, Human | 1 | 2015 | 50 | 0.500 |
Why?
|
| Tendinopathy | 4 | 2019 | 61 | 0.490 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 82 | 0.490 |
Why?
|
| Synovial Membrane | 4 | 2012 | 84 | 0.480 |
Why?
|
| Cells, Cultured | 16 | 2020 | 686 | 0.460 |
Why?
|
| Hyaluronan Synthases | 4 | 2018 | 8 | 0.450 |
Why?
|
| Alpha-Globulins | 2 | 2011 | 7 | 0.450 |
Why?
|
| Glucose | 3 | 2019 | 65 | 0.440 |
Why?
|
| Joints | 3 | 2009 | 99 | 0.430 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 782 | 0.420 |
Why?
|
| Knee Joint | 5 | 2015 | 826 | 0.420 |
Why?
|
| Electrophoresis | 9 | 2010 | 17 | 0.420 |
Why?
|
| Mice, Knockout | 8 | 2018 | 323 | 0.420 |
Why?
|
| Molecular Sequence Data | 13 | 2009 | 247 | 0.400 |
Why?
|
| Biomechanical Phenomena | 11 | 2019 | 698 | 0.400 |
Why?
|
| Glycoside Hydrolases | 3 | 2001 | 3 | 0.400 |
Why?
|
| Dermis | 1 | 2011 | 7 | 0.380 |
Why?
|
| Sequence Deletion | 1 | 2011 | 13 | 0.380 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 9 | 0.370 |
Why?
|
| Gene Silencing | 1 | 2010 | 24 | 0.370 |
Why?
|
| Stifle | 1 | 2010 | 12 | 0.360 |
Why?
|
| Hyperalgesia | 1 | 2011 | 52 | 0.360 |
Why?
|
| Glioma | 1 | 2010 | 54 | 0.350 |
Why?
|
| Tissue Engineering | 4 | 2019 | 39 | 0.340 |
Why?
|
| Protein Biosynthesis | 6 | 1996 | 27 | 0.340 |
Why?
|
| Humans | 42 | 2020 | 30997 | 0.340 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 132 | 0.330 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 133 | 0.330 |
Why?
|
| Rats | 9 | 2020 | 873 | 0.330 |
Why?
|
| Swine | 1 | 2008 | 92 | 0.310 |
Why?
|
| Growth Plate | 4 | 2008 | 24 | 0.310 |
Why?
|
| Rabbits | 13 | 2009 | 286 | 0.300 |
Why?
|
| Tendons | 2 | 2018 | 229 | 0.290 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 430 | 0.290 |
Why?
|
| Disaccharides | 5 | 2005 | 5 | 0.290 |
Why?
|
| Software | 1 | 2007 | 72 | 0.280 |
Why?
|
| Carbohydrate Sequence | 7 | 2001 | 15 | 0.280 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 6 | 2008 | 29 | 0.270 |
Why?
|
| Chondrogenesis | 3 | 2020 | 31 | 0.270 |
Why?
|
| Stem Cells | 2 | 2020 | 49 | 0.260 |
Why?
|
| Inflammation | 2 | 2020 | 362 | 0.260 |
Why?
|
| Aging | 6 | 2012 | 1727 | 0.260 |
Why?
|
| Models, Biological | 1 | 2007 | 346 | 0.250 |
Why?
|
| beta-Galactosidase | 3 | 2001 | 8 | 0.250 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2016 | 8 | 0.250 |
Why?
|
| Cornea | 2 | 2001 | 10 | 0.240 |
Why?
|
| Acetylglucosaminidase | 2 | 2001 | 5 | 0.240 |
Why?
|
| Sulfur | 2 | 2003 | 5 | 0.230 |
Why?
|
| Arthralgia | 2 | 2019 | 133 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 168 | 0.220 |
Why?
|
| Polyelectrolytes | 1 | 2023 | 2 | 0.220 |
Why?
|
| Chondroitin Lyases | 4 | 1999 | 6 | 0.210 |
Why?
|
| Chromatography, Ion Exchange | 6 | 2001 | 12 | 0.210 |
Why?
|
| Molecular Weight | 3 | 2020 | 45 | 0.200 |
Why?
|
| Extracellular Matrix | 4 | 2015 | 75 | 0.200 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2001 | 1 | 0.200 |
Why?
|
| Fibromodulin | 8 | 2019 | 15 | 0.190 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2019 | 4 | 0.190 |
Why?
|
| Biomarkers | 3 | 2020 | 733 | 0.190 |
Why?
|
| X-Ray Microtomography | 3 | 2022 | 81 | 0.180 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2020 | 7 | 0.180 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2020 | 22 | 0.180 |
Why?
|
| Administration, Oral | 4 | 2009 | 139 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 27 | 0.180 |
Why?
|
| Blotting, Western | 7 | 2011 | 178 | 0.180 |
Why?
|
| Phagocytosis | 1 | 2020 | 52 | 0.180 |
Why?
|
| Amino Acid Sequence | 7 | 2009 | 195 | 0.180 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 29 | 0.180 |
Why?
|
| Scleroderma, Systemic | 1 | 2020 | 18 | 0.180 |
Why?
|
| Calcinosis | 1 | 2020 | 50 | 0.180 |
Why?
|
| Cell Separation | 1 | 2020 | 43 | 0.170 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2000 | 8 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 133 | 0.170 |
Why?
|
| Fibrillar Collagens | 1 | 2019 | 2 | 0.170 |
Why?
|
| Trisaccharides | 1 | 1999 | 4 | 0.170 |
Why?
|
| Rotator Cuff | 2 | 2020 | 283 | 0.170 |
Why?
|
| Cell Proliferation | 1 | 2020 | 204 | 0.170 |
Why?
|
| Bursitis | 1 | 2019 | 12 | 0.170 |
Why?
|
| Macrophages | 1 | 2020 | 137 | 0.170 |
Why?
|
| Meniscus | 1 | 2019 | 21 | 0.170 |
Why?
|
| Female | 13 | 2017 | 16983 | 0.160 |
Why?
|
| Osteolysis | 1 | 2020 | 147 | 0.160 |
Why?
|
| Phenotype | 1 | 2020 | 379 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 167 | 0.160 |
Why?
|
| Contrast Media | 2 | 2017 | 136 | 0.160 |
Why?
|
| Calcaneus | 1 | 2018 | 7 | 0.160 |
Why?
|
| Oligosaccharides | 4 | 2001 | 25 | 0.160 |
Why?
|
| Bursa, Synovial | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cattle Diseases | 1 | 1998 | 1 | 0.160 |
Why?
|
| DNA | 4 | 2015 | 124 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2018 | 16 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 17 | 0.160 |
Why?
|
| Injections, Intra-Articular | 3 | 2019 | 97 | 0.150 |
Why?
|
| Chondroitin | 3 | 2010 | 6 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 211 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 222 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2001 | 37 | 0.140 |
Why?
|
| Aminopyridines | 1 | 1996 | 3 | 0.140 |
Why?
|
| Chromatin | 1 | 2016 | 15 | 0.140 |
Why?
|
| Pyrroles | 1 | 2016 | 25 | 0.140 |
Why?
|
| Time Factors | 8 | 2012 | 1672 | 0.140 |
Why?
|
| Decorin | 5 | 2019 | 17 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 63 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2016 | 54 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2001 | 36 | 0.130 |
Why?
|
| Chondroitin ABC Lyase | 3 | 2007 | 6 | 0.130 |
Why?
|
| Embryo, Mammalian | 2 | 2008 | 30 | 0.130 |
Why?
|
| Cyclopentanes | 1 | 1995 | 4 | 0.130 |
Why?
|
| Viral Core Proteins | 1 | 1995 | 4 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2016 | 134 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2015 | 532 | 0.130 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2012 | 32 | 0.120 |
Why?
|
| Antigens | 1 | 1995 | 27 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 28 | 0.120 |
Why?
|
| Amino Sugars | 1 | 1993 | 1 | 0.120 |
Why?
|
| Polysaccharides | 1 | 1993 | 16 | 0.110 |
Why?
|
| Macromolecular Substances | 7 | 2005 | 17 | 0.110 |
Why?
|
| Cell Aggregation | 2 | 2011 | 2 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 271 | 0.110 |
Why?
|
| Kinetics | 7 | 2008 | 226 | 0.110 |
Why?
|
| Histological Techniques | 1 | 1993 | 6 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 59 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1998 | 150 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 442 | 0.100 |
Why?
|
| Heparin | 2 | 2010 | 25 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2012 | 8 | 0.100 |
Why?
|
| Aged | 8 | 2007 | 10048 | 0.100 |
Why?
|
| Running | 1 | 2012 | 13 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 2 | 2013 | 7 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2008 | 98 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 64 | 0.100 |
Why?
|
| Fibril-Associated Collagens | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 272 | 0.100 |
Why?
|
| Transcriptome | 1 | 2012 | 89 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2012 | 113 | 0.100 |
Why?
|
| Activin Receptors | 1 | 2011 | 1 | 0.100 |
Why?
|
| Epithelioid Cells | 1 | 2011 | 1 | 0.100 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2011 | 1 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2011 | 9 | 0.100 |
Why?
|
| Activin Receptors, Type II | 1 | 2011 | 2 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 3 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 107 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2011 | 59 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 43 | 0.090 |
Why?
|
| Collagen | 3 | 2018 | 103 | 0.090 |
Why?
|
| Heparitin Sulfate | 3 | 2010 | 6 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2011 | 164 | 0.090 |
Why?
|
| Middle Aged | 8 | 2011 | 10195 | 0.090 |
Why?
|
| Sulfates | 6 | 2006 | 16 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 69 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2010 | 204 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 428 | 0.090 |
Why?
|
| Dogs | 2 | 2009 | 263 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2001 | 11 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 298 | 0.080 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 4 | 2016 | 6 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2019 | 254 | 0.080 |
Why?
|
| Disulfides | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2009 | 19 | 0.080 |
Why?
|
| Adolescent | 3 | 2001 | 2401 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2009 | 112 | 0.080 |
Why?
|
| Isomerism | 2 | 1999 | 3 | 0.080 |
Why?
|
| Apoptosis | 1 | 2010 | 260 | 0.080 |
Why?
|
| Joint Capsule | 1 | 2009 | 46 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2008 | 8 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2008 | 22 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2007 | 222 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2001 | 55 | 0.080 |
Why?
|
| Stress, Mechanical | 5 | 2010 | 173 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 5 | 0.080 |
Why?
|
| Immune System | 1 | 2008 | 26 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2008 | 7 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2008 | 22 | 0.080 |
Why?
|
| Fucose | 2 | 2001 | 2 | 0.080 |
Why?
|
| Chromatography, Gel | 4 | 2010 | 15 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 234 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 225 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 40 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 221 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2008 | 63 | 0.080 |
Why?
|
| Molecular Structure | 3 | 2003 | 29 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2008 | 46 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 4 | 2010 | 9 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 2 | 2006 | 23 | 0.070 |
Why?
|
| Systems Biology | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cryptococcus neoformans | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glycosyltransferases | 1 | 2007 | 1 | 0.070 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 7 | 0.070 |
Why?
|
| Body Temperature | 1 | 2007 | 58 | 0.070 |
Why?
|
| Gait | 1 | 2011 | 407 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 107 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 118 | 0.070 |
Why?
|
| Proteins | 2 | 1991 | 73 | 0.070 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2006 | 3 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Adult | 7 | 2011 | 8931 | 0.070 |
Why?
|
| Alkalies | 1 | 1986 | 3 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2006 | 52 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 4 | 1996 | 13 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 81 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 103 | 0.070 |
Why?
|
| Pain | 1 | 2009 | 426 | 0.070 |
Why?
|
| Culture Techniques | 5 | 1997 | 24 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2006 | 65 | 0.070 |
Why?
|
| Nanostructures | 1 | 2005 | 13 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 43 | 0.060 |
Why?
|
| Biglycan | 3 | 2000 | 17 | 0.060 |
Why?
|
| Ioxaglic Acid | 2 | 2017 | 5 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 29 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2005 | 11 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 56 | 0.060 |
Why?
|
| Tritium | 3 | 1996 | 14 | 0.060 |
Why?
|
| Algorithms | 1 | 2007 | 414 | 0.060 |
Why?
|
| Organ Culture Techniques | 3 | 1996 | 29 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2003 | 3 | 0.060 |
Why?
|
| Epitopes | 3 | 2009 | 88 | 0.060 |
Why?
|
| Protein Binding | 4 | 2003 | 124 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2003 | 25 | 0.060 |
Why?
|
| Sulfotransferases | 2 | 2003 | 6 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1989 | 12 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2003 | 72 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2003 | 106 | 0.050 |
Why?
|
| Leucine | 2 | 1996 | 15 | 0.050 |
Why?
|
| Chromatography | 2 | 1995 | 3 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2001 | 689 | 0.050 |
Why?
|
| Chondrosarcoma | 2 | 1999 | 37 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 2 | 0.050 |
Why?
|
| Fetus | 2 | 2000 | 59 | 0.050 |
Why?
|
| Acetylglucosamine | 1 | 2001 | 2 | 0.050 |
Why?
|
| Glycopeptides | 1 | 2001 | 5 | 0.050 |
Why?
|
| Tail | 1 | 2001 | 4 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 28 | 0.050 |
Why?
|
| P-Selectin | 1 | 2000 | 3 | 0.050 |
Why?
|
| L-Selectin | 1 | 2000 | 17 | 0.050 |
Why?
|
| Reference Values | 2 | 1998 | 229 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 21 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 57 | 0.040 |
Why?
|
| Age Factors | 2 | 1997 | 873 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 46 | 0.040 |
Why?
|
| Skin | 1 | 2000 | 124 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 24 | 0.040 |
Why?
|
| Injections | 1 | 2019 | 59 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 29 | 0.040 |
Why?
|
| Regeneration | 1 | 2019 | 27 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2011 | 365 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 243 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 165 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2000 | 110 | 0.040 |
Why?
|
| Rotator Cuff Injuries | 2 | 2020 | 298 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 75 | 0.040 |
Why?
|
| Small Leucine-Rich Proteoglycans | 1 | 2018 | 1 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 1998 | 1 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1996 | 54 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1998 | 12 | 0.040 |
Why?
|
| Biological Transport | 2 | 1995 | 44 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 14 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 370 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 23 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Nanotechnology | 2 | 2010 | 11 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 8 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2005 | 70 | 0.040 |
Why?
|
| Weight-Bearing | 2 | 2012 | 170 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 147 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 57 | 0.040 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 1997 | 9 | 0.040 |
Why?
|
| Tretinoin | 1 | 1997 | 15 | 0.040 |
Why?
|
| Trypsin | 1 | 2017 | 6 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 1997 | 79 | 0.040 |
Why?
|
| Immunoassay | 1 | 1997 | 45 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 34 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1997 | 59 | 0.040 |
Why?
|
| Monosaccharides | 1 | 1996 | 2 | 0.040 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 2 | 2010 | 6 | 0.030 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 27 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 19 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 81 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1996 | 10 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 1801 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 55 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3806 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 305 | 0.030 |
Why?
|
| ADAMTS4 Protein | 2 | 2007 | 19 | 0.030 |
Why?
|
| Procollagen N-Endopeptidase | 2 | 2007 | 16 | 0.030 |
Why?
|
| Infant | 1 | 1997 | 578 | 0.030 |
Why?
|
| Brefeldin A | 1 | 1995 | 3 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 4 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 11 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 7 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2015 | 7 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2015 | 10 | 0.030 |
Why?
|
| Syndecans | 2 | 2006 | 2 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 320 | 0.030 |
Why?
|
| Syndecan-1 | 2 | 2006 | 8 | 0.030 |
Why?
|
| Ribs | 1 | 1995 | 18 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 36 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 135 | 0.030 |
Why?
|
| Mannosidases | 1 | 1993 | 1 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hydroxyproline | 2 | 2010 | 7 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 14 | 0.030 |
Why?
|
| Integrins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 22 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 2003 | 215 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2006 | 329 | 0.030 |
Why?
|
| Tibia | 1 | 1995 | 274 | 0.030 |
Why?
|
| Hindlimb | 1 | 2012 | 25 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 126 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Tunicamycin | 1 | 1990 | 2 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 6 | 0.020 |
Why?
|
| Amino Acids | 1 | 1990 | 22 | 0.020 |
Why?
|
| Glycosylation | 1 | 1990 | 24 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1990 | 84 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 130 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 9 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1989 | 9 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 68 | 0.020 |
Why?
|
| Ankle Injuries | 1 | 2009 | 13 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 164 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 10 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 11 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 37 | 0.020 |
Why?
|
| Streptomyces | 1 | 1989 | 1 | 0.020 |
Why?
|
| Silver Staining | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 43 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 246 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 67 | 0.020 |
Why?
|
| Femur | 1 | 2012 | 402 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 9 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 32 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 97 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 47 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 158 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 330 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2008 | 97 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 261 | 0.020 |
Why?
|
| Proline | 3 | 1994 | 19 | 0.020 |
Why?
|
| Escherichia | 1 | 2007 | 1 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 7 | 0.020 |
Why?
|
| Biological Assay | 1 | 2007 | 9 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Virulence | 1 | 2007 | 16 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 9 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 19 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 5 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2007 | 13 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 8 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 13 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2009 | 489 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 4 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 75 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2007 | 16 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 83 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 113 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2006 | 16 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2006 | 8 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2006 | 27 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2007 | 107 | 0.020 |
Why?
|
| Microcirculation | 1 | 2006 | 42 | 0.020 |
Why?
|
| Arthritis | 1 | 2007 | 105 | 0.020 |
Why?
|
| Methylene Blue | 1 | 1986 | 2 | 0.020 |
Why?
|
| Half-Life | 1 | 1986 | 15 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1985 | 2 | 0.020 |
Why?
|
| Methods | 1 | 1985 | 17 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1985 | 23 | 0.020 |
Why?
|
| Bone Density | 1 | 2007 | 152 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 75 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 1897 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 40 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2005 | 33 | 0.020 |
Why?
|
| Static Electricity | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 45 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 53 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 134 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2007 | 281 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 104 | 0.020 |
Why?
|
| Cell Division | 1 | 1984 | 113 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Endopeptidase K | 1 | 2003 | 5 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 13 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 9 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 19 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 9 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 71 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 2063 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 91 | 0.010 |
Why?
|
| Hydrostatic Pressure | 2 | 1994 | 3 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 409 | 0.010 |
Why?
|
| Biotinylation | 1 | 2000 | 2 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 28 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 18 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2000 | 33 | 0.010 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2000 | 1 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 149 | 0.010 |
Why?
|
| Cicatrix | 1 | 2000 | 12 | 0.010 |
Why?
|
| Pressure | 2 | 1991 | 63 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 78 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 113 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 177 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 468 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 583 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1997 | 7 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1997 | 5 | 0.010 |
Why?
|
| Dipeptides | 1 | 1997 | 4 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 13 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 124 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1995 | 14 | 0.010 |
Why?
|
| Gap Junctions | 1 | 1995 | 12 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 73 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 11 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1994 | 12 | 0.010 |
Why?
|
| Diffusion | 1 | 1994 | 28 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1994 | 83 | 0.010 |
Why?
|
| Menisci, Tibial | 1 | 1995 | 187 | 0.010 |
Why?
|
| RNA, Transfer, Pro | 1 | 1989 | 1 | 0.010 |
Why?
|
| Hexuronic Acids | 1 | 1984 | 10 | 0.000 |
Why?
|